This week, we will discuss why a large registry cohort was needed to move past decades of scattered case reports and clarify the true risk of hydralazine‑associated vasculitis. When rare events hide in noise, only scale can reveal the signal. Can population‑level data finally bring this paradox into focus?
Summary of the STEPS trial which will be a twitter spaces discussion
This week, we will discuss the HIT trial- a large randomized study challenging one of the most reflexive responses in hospital medicine: see hyponatremia, fix the sodium. But what if correcting the number doesn’t change what actually matters?
Un gran registro poblacional era esencial para superar décadas de reportes aislados y cuantificar por fin el riesgo real de la vasculitis asociada a hidralazina. Cuando los eventos raros se confunden con el ruido de fondo, solo la escala permite distinguir la señal. ¿Puede la evidencia a nivel poblacional aclarar por fin este panorama?
Revisa el resumen visual por Divya Bajpai , traducir por Milagros Flores
